» Download Public Reports
21 reports
- Industry report
- April 2013
- 8 pages
... Innovation in biologics will be the theme of this meeting. Among the biologic drug cands, monoclonal antibody (mab) is the fastest growing area of global pharmaceutical market. Mab is set to lead ...
May 2012
... A major technical challenge in the cost-effective production of cellulosic biofuel is the need to lower the cost of plant cell wall degrading enzymes (pcde), which is required for the production of sugars ...
May 2012
... This provisional pdf corresponds to the article as it appeared upon acceptance. Fully formatted pdf and full text (html) versions will be made available soon. biosimilars; a unique opportunity ...
May 2012
... And production of monoclonal antibodies and antibody-based protein drugs. We carry out environmental management activities that meet the company S mid- to long-term strategies and the policies of its ...
November 2011
... And export recovery aided by slowed appreciation of the won against the us dollar; and 3) visible results from new drugs, as in the out- licensing of a sustained-release human growth hormone (sr ...
June 2011
... Transfer of technology and global sales rights of enbrel biosimilar hd203 to merck. We see limited impact on celltrion as developing biosimilar enbrel is difficult. Celltrion S expected launch of ct-p13 ...
June 2011
... Highly risk less competitors high investment medium term no patent rightlong term vaccines / plasma derivatives others moderate market medium risk limited market, yet less competitors high entry ...
June 2011
... Papillomavirus kim keywords: human papillomavirus virus-like particle the study, we investigated l1 protein productivity as a function of the composition of the carbon source and to gardasil (merck ...
April 2011
... Margin of bio subsidiaries at 18%. We forecast the 2011f nucleic acid price to drop to an annual average of usd14.520/Kg, but the lysine price should remain strong thanks to china S growing demand ...
» Purchase Premium Reports
(From $ 250 - $ 2 488)
11 reports
- $ 2 488
- Industry report
- June 2013
- by MarketSizeInfo
Global Vaccine Market to 2017 - Market Size, Growth and Forecasts in Over 70 Countries is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market ...
May 2013
$ 2 064
Product Description The new Competitive Intelligence Report Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis of the product portfolios and development ...
May 2013
$ 250
Summary Genexine Co., Ltd. (Genexine) is a research and development company, based in Korea. The company develops therapeutic vaccines for incurable diseases and next-generation antibody fusion protein ...
May 2013
$ 250
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
